Company news
Inhalation Sciences Sweden AB news in 2026
Inhalation Sciences Sweden AB's news releases, calls and decks from 2026, newest first.
Inhalation Sciences to present the compelling results from the FDA-funded evaluation study of DissolvIt® at leading respiratory and inhalation drug development conferences
August 20, 2026
Inhalation Sciences receives IRS order worth approximately EUR 117,000
May 18, 2026
ISAB: Revenue and order intake surged, losses narrowed, and acquisition talks are advancing
May 11, 2026
Inhalation Sciences: Inhalation Sciences secures additional PreciseInhale® service orders worth SEK 350,000
March 24, 2026
Inhalation Sciences secures additional PreciseInhale® service orders worth SEK 350,000
March 24, 2026
ISAB: Sharp revenue drop and ongoing losses; financing and going concern remain key risks
February 27, 2026
Inhalation Sciences receives new IRS order for DissolvIt® worth approximately EUR 139,000
February 18, 2026
Inhalation Sciences: Inhalation Sciences receives new IRS orders worth EUR 52,000 from global pharmaceutical companies
January 27, 2026
Inhalation Sciences receives new IRS orders worth EUR 52,000 from global pharmaceutical companies
January 27, 2026